Navigation Links
Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:6/3/2010

/span>

A Phase 1 study of ABT-888 in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas; S. Kummar et al.

  • Abstract 2605; Poster Session; June 7, 2010; 8 a.m. - 12 p.m. Location: S Hall A2; Poster board number: 9C.

Targeting Fanconi Anemia (FA) repair pathway deficiency for treatment with PARP inhibitors; W. Zhao et al.

  • Abstract TPS168; Trials in Progress Poster Session; June 7, 2010; 8 a.m. - 12 p.m.; Location: S Hall A2; Poster number: 8.

Pharmacodynamic response in Phase 1 combination study of ABT-888 and Topotecan in adults with refractory solid tumors and lymphomas; J .Ji et al.

  • Abstract 2514; Oral Abstract Session; June 8, 2010; 9:30 a.m. - 12:30 p.m.; Location: E354a; Presentation time: 12 p.m.

Navitoclax (ABT-263)

A phase 2a study of ABT-263 in patients with relapsed small-cell lung cancer (SCLC); C.M. Rudin, et al.

  • Abstract 7046: Poster Session; June 6, 2010; 8 a.m. - 12 p.m.; Location: S Hall A2; poster number: 21D.

Elotuzumab (HuLuc63)

Elotuzumab in combination with bortezomib in patients with relapsed/refractory multiple mye
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
3. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
4. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
5. Assegai Wins Big Settlement Against ABBOTTs Subsidiary
6. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
7. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
8. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
9. Abbott Completes Acquisition of Facet Biotech
10. Abbott Completes Acquisition of STARLIMS Technologies
11. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... added to the Russell 1000 Index, effective June 26, ... the large-cap segment of the U.S. equity universe. It ... includes approximately 1000 of the largest securities based on ... membership. "We are pleased to be added ...
(Date:6/29/2015)... Axxess , an industry leader in ... vendor accredited by the American Nursing Credentialing Center – ... agencies select the right revenue cycle management (RCM) system ... business. Research by American Health Information Management ... a decrease in productivity of 54.4 - 69 percent ...
(Date:6/29/2015)... 29, 2015  Arbor Solution has added another ... high-powered, multi-functional M2150 offers two platforms: ... Core i5-4402E 1.6 GHz processor and i5-4422E ... and computing performance. Integrated Intel® HD Graphics 4600 ... suited for graphics-intense applications in operating rooms, clinical ...
Breaking Medicine Technology:ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... N.J., July 05, 2007 /PRNewswire/ -- Results ... open-label, Phase,3 study showed that 77 percent ... 600 mg tablets with,100 mg ritonavir (PREZISTA/r) ... of antiretroviral (ARV) agents, reached a,plasma viral ...
... 2007 - ZIOPHARM,Oncology, Inc. (NASDAQ: ZIOP) announces ... II trial of ZIO-201 (isophosphoramide mustard,- IPM) ... at the,European Society of Medical Oncology (ESMO) ... The abstract entitled, "Phase-I/II,Study of IPM (ZIO-201) ...
Cached Medicine Technology:New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
(Date:6/29/2015)... ... June 29, 2015 , ... The Mesothelioma ... part of its support program. This discussion series is part of the Meso ... services to those affected by mesothelioma. , The six week discussion series is ...
(Date:6/29/2015)... , ... June 29, 2015 , ... Displays and ... imprinted accessories, is offering discounted pricing on all purchases that include branding. Enter price ... a brand is the logo. The website, packaging and promotional materials, all should integrate ...
(Date:6/29/2015)... Wethersfield, CT (PRWEB) , ... June 29, 2015 ... ... their centers recognized by the independent auditor of customer service for the 40-center ... of more than 1,100 skilled nursing centers in the United States in one ...
(Date:6/29/2015)... ... June 29, 2015 , ... Assurex Health, ... with certain neuropsychiatric and chronic pain conditions, has announced appointments to three key ... include: Peter Donato, Senior Vice President, Chief Financial Officer; Craig S. Lewis, Senior ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... Conference shows that fewer than 10 percent of U.S. state and local governments ... have set an implementation deadline for NG9-1-1. , “Mobile phones have surpassed ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 2Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 3Health News:State and Local Governments Are Slow to Adopt Next Generation 9-1-1 Systems, According to New Research from General Dynamics Information Technology 4
... ion beams developed at GSI is characterized by an excellent ... been routinely in use for a little over one year. ... the tumor type, but also on the genetic disposition and ... first time, scientists at GSI Helmholtzzentrum fr Schwerionenforschung have irradiated ...
... FRIDAY, Dec. 17 (HealthDay News) -- Children and adults with ... higher risk of death than those with other types of ... known as lupus, affects one or more parts of the ... Up to 80 percent of children with lupus suffer kidney ...
... Graph app, researchers in the ADVANCE project at NJIT ... help women scientists and engineers supercharge their careers. ... sheets. They,re webs of human interaction," said Nancy Steffen-Fluhr, ... and the ADVANCE project leader. "The complex structure of ...
... HealthDay Reporter , THURSDAY, Dec. 16 (HealthDay News) -- U.S. ... type of brain cancer in children. Gene sequencing reveals ... abnormalities than comparable adult tumors. The discovery that MB ... tumors could further attempts to understand what triggers the cancer ...
... hard time keeping a lid on their feelings, especially ... reality shows, psychologists have found. But they,re better than ... a stressful situation and empathizing with the less fortunate, ... A team of researchers led by UC ...
... Italy determined that radiofrequency ablation (RFA) is a safe ... cirrhotic patients. The high repeatability of RFA is advantageous ... Results of this 10-year retrospective study are available in ... journal published by Wiley-Blackwell on behalf of the American ...
Cached Medicine News:Health News:Samples of vital human tumor tissue irradiated with ions for the first time 2Health News:Kidney Disease Could Be More Deadly for Kids With Lupus 2Health News:Mapping faculty social networks helps female faculty move ahead at NJIT 2Health News:Mapping faculty social networks helps female faculty move ahead at NJIT 3Health News:Gene Research Brings Insight Into Deadly Childhood Brain Tumor 2Health News:Emotional intelligence peaks as we enter our 60s, research suggests 2Health News:Emotional intelligence peaks as we enter our 60s, research suggests 3Health News:Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation 2
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Castroviejo straight tying forceps, straight shafts, 5 mm tying platforms, wide handle....
Shepard tying forceps, round curved platform 8 mm, 8.5 cm....
Medicine Products: